Prophylactic use of granulocyte colony-stimulating factor after chemotherapy does not affect survival rate in acute myeloid leukemia: A meta-analysis

Acta Haematologica

Volumn 121, Issue 4, 2009, Pages 223-226

  Wang, Jing ^a   An, Li ^b   Chen, Shi ^c   Ouyang, Jian ^a,d   Zhou, Rongfu ^a   Chen, Bing ^a   Yang, Yonggong ^a  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

^b SOUTHEAST UNIVERSITY   (China)

^c Nanjing Second Hospital   (China)

^d NANJING UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; CANCER CHEMOTHERAPY; CANCER REGRESSION; CANCER SURVIVAL; CLINICAL TRIAL; HUMAN; META ANALYSIS; PRIORITY JOURNAL; PROPHYLAXIS; SENSITIVITY ANALYSIS; STEM CELL; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

ACUTE DISEASE; ADOLESCENT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; FILGRASTIM; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; LEUKEMIA, MYELOID; MIDDLE AGED; NEUTROPENIA; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECOMBINANT PROTEINS;

EID: 67449138488     PISSN: 00015792     EISSN: None     Source Type: Journal    
DOI: 10.1159/000225909     Document Type: Article

References (15)

1. Sung L, Alibhai SMH, Beyene J, Gamis A, Almeida R, Smith S, Aplenc R: Hematopoietic colony-stimulating factor priming does not influence survival in acute myeloid leukemia: a meta-analysis of randomized trials. Leukemia 2009; 23: 811-813. DOI: 10.1038/leu.2008.305.
2. Wang J, Zhan P, Ouyang J, Chen B, Zhou R: Prophylactic use of granulocyte colony-stimulating factor after induction chemotherapy in patients with newly diagnosed acute myeloid leukemia may increase the complete remission rate: a meta-analysis of five randomised controlled trials. Leuk Lymphoma 2009; 50: 457-459.
3. Parmar MK, Torri V, Stewart L: Extracting summary statistics to performmeta-analyses of the published literature for survival endpoints. Stat Med 1998; 17: 2815-2834. (Pubitemid 28562978)
4. van Tulder M, Furlan A, Bombardier C, Bouter L; Editorial Board of the Cochrane Collaboration Back Review Group: Updated method guidelines for systematic reviews in the cochrane collaboration back review group. Spine 2003; 28: 1290-1299.
5. Dombret H, Chastang C, Fenaux P, Reiffers J, Bordessoule D, Bouabdallah R, Mandelli F, Ferrant A, Auzanneau G, Tilly H, Yver A, Degos L; AML Cooperative Study Group: A controlled study of recombininat human granulocyte colony-stimulating factor in elderly patients after treatment for acute myelogenous leukemia. N Engl J Med 1995; 332: 1678-1683.
6. Heil G, Hoelzer D, Sanz MA, Lechner K, Liu Yin JA, Papa G, Noens L, Szer J, Ganser A, O'Brien C, Matcham J, Barge A: A randomized, double-blind, placebo-controlled, phase III study of filgrastim in remission induction and consolidation therapy for adults with de novo acute myeloid leukemia. Blood 1997; 90: 4710-4718. (Pubitemid 28007183)
7. Godwin JE, Kopecky KJ, Head DR, Willman CL, Leith CP, Hynes HE, Balcerzak SP, Applebaum FR: A double-blind placebo-controlled trial of granulocyte colony-stimulating factor in elderly patients with previously untreated acute myeloid leukemia:a southwest oncology group study (9031). Blood 1998; 91: 3607-3615.
8. Harousseau JL, Witz B, Lioure B, Hunault-Berger M, Desablens B, Delain M, Guilhot F, Le Prise PY, Abgrall JF, Deconinck E, Guyotat D, Vilque JP, Casassus P, Tournilhac O, Audhuy B, Solary E: Granulocyte colony-stimulating factor after intensive consolidation chemotherapy in acute myeloid leukemia: results of a randomized trial of the Groupe Ouest-Est Leucémies Aigues Myeloblastiques. J Clin Oncol 2000; 18: 780-787. (Pubitemid 30106608)
9. Bradstock K, Matthews J, Young G, Lowenthal R, Baxter H, Arthur C, Bashford J, Brighton T, Cannell P, Dunlop L, Durrant S, Enno A, Eliadis P, Gill D, Gillett A, Gottleib D, Januszewicz H, Joshua D, Leahy M, Schwarer A, Taylor K; Australian Leaukaemia Study Group: Effects of glycosylated recombinant human granulocyte colony-stimulating factor after high-dose cytarabine-based induction chemotherapy for adult acute myeloid leukaemia. Leukemia 2001; 15: 1331-1338. (Pubitemid 32785302)
10. Usuki K, Urabe A, Masaoka T, Ohno R, Mizoguchi H, Hamajima N, Miyazaki T, Niitsu Y, Yoshida Y, Miura A, Shibata A, Abe T, Miura Y, Ikeda Y, Nomura T, Nagae T, Saitou H, Shirakawa S, Ohkuma M, Matsuda T, Nakamura T, Horiuchi A, Kuramoto A, Kimura I, Irino S, Niho Y, Takatsuki K, Tomonaga M, Uchino H, Takaku F; Gran AML Study Group: Efficacy of granulocyte colony-stimulating factor in the treatment of acute myelogenous leukaemia: a multicentre randomized study. Br J Haematol 2002; 116: 103-112. (Pubitemid 34122066)
11. Amadori S, Suciu S, Jehn U, Stasi R, Thomas X, Marie JP, Muus P, Lefrère F, Berneman Z, Fillet G, Denzlinger C, Willemze R, Leoni P, Leone G, Casini M, Ricciuti F, Vignetti M, Beeldens F, Mandelli F, De Witte T; EORTC/GIMEMA Leukemia Group: Use of glycosylated recombinant human G-CSF (lenograstim) during and/or after induction chemotherapy in patients 61 years of age and older with acute myeloid leukemia: final results of AML-13, a randomized phase-3 study. Blood 2005; 106: 27-34. (Pubitemid 40967170)
12. Goldstone AH, Burnett AK, Wheatley K, Smith AG, Hutchinson RM, Clark RE; Medical Reasearch Council Adult Leukemia Work Party: Attempts to improve treatment outcomes in acute myeloid leukemia (AML) in older patients: the results of the United Kingdom Medical Research Council AML11 trial. Blood 2001; 98: 1302-1311.
13. Lehrnbecher T, Zimmermann M, Reinhardt D, Dworzak M, Stary J, Creutzig U: Prophylactic human granulocyte colony-stimulating factor after induction therapy in pediatric acute myeloid leukemia. Blood 2007; 10: 936-943. (Pubitemid 46220636)
14. Estey EH: Therapeutic options for acute myelogenous leukemia. Cancer 2001; 92: 1059-1073. (Pubitemid 32861652)
15. British Committee for Standards in Haematology, Milligan DW, Grimwade D, Cullis JO, Bond L, Swirsky D, Craddock C, Kell J, Homewood J, Campbell K, McGinley S, Wheatley K, Jackson G: Guidelines on the management of acute myeloid leukemia in adults. Br J Haematol 2006; 135: 450-474.